DS
David Sommerhalder
Physician · Methodist Hospital
Credentials: · · · · · · ·
History
- 2020–Present
- 2009–2013
Research
A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1/1b trial
Nature Medicine · 2025 · 86 citations
Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial
Nature Medicine · 2024 · 46 citations
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer
New England Journal of Medicine · 2026 · 24 citations
- AS
5 papers
4 papers
4 papers
- AS
3 papers
3 papers
- MJ
3 papers
- MP
3 papers
- MB
3 papers
